Related Experiment Video

Updated: Feb 14, 2026

The Spared Nerve Injury SNI Model of Induced Mechanical Allodynia in Mice
07:44

The Spared Nerve Injury SNI Model of Induced Mechanical Allodynia in Mice

Published on: August 18, 2011

65.2K

The search for new antithrombotic mechanisms and therapies that may spare hemostasis

Edward F Plow1, Yunmei Wang2, Daniel I Simon2

  • 1Cleveland Clinic Foundation; and.

Blood
|February 23, 2018
PubMed

Insights

New antithrombotic therapies aim to reduce bleeding risk by targeting distinct molecular mechanisms. Researchers highlight the interaction between leukocyte integrin αMβ2 and platelet GPIbα as a potential target to separate thrombosis from hemostasis.

Area of Science:

  • Biomedical Science
  • Hematology
  • Pharmacology

Background:

  • Current antithrombotic drugs (antiplatelet agents, anticoagulants) carry a significant risk of bleeding.
  • Emerging evidence suggests separating hemostasis and thrombosis mechanisms may yield safer antithrombotic targets.

Purpose of the Study:

  • To review novel coagulation and platelet targets for antithrombotic therapy.
  • To highlight specific molecular interactions that differentiate thrombosis from hemostasis.

Main Methods:

  • Review of current literature on antithrombotic mechanisms.
  • Analysis of molecular interactions between leukocytes and platelets in thrombosis and hemostasis.

Main Results:

  • Identification of new potential targets in coagulation and platelet pathways.
  • Emphasis on the interaction between integrin αMβ2 (Mac-1) on leukocytes and GPIbα on platelets.

Conclusions:

  • The interaction between leukocyte integrin αMβ2 and platelet GPIbα may offer a way to selectively inhibit thrombosis while preserving hemostasis.
  • This interaction represents a promising therapeutic target for developing antithrombotic agents with a reduced bleeding risk.

More Related Videos

Author Spotlight: Exploring Behavioral Pathways Through Cross-Species Insights in Foraging and Communication03:53

Author Spotlight: Exploring Behavioral Pathways Through Cross-Species Insights in Foraging and Communication

Published on: November 17, 2023

1.6K
Retzius-Sparing Robot-Assisted Radical Prostatectomy12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.4K

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.3K
Spare Receptors01:30

Spare Receptors

Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
4.6K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.2K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.4K